Kiniksa Pharmaceuticals Quote - KNSA

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

19.69

Bid

19.54

Ask

20.30

Volume

215,311

19.31 Day's Range 19.81

16.56 52 Week Range 28.15

Market Cap

1.422B

Previous Close

19.72

Open

19.63

Last Trade

19.69

Last Trade Time

Financial Volume

US$ 4,215,613

VWAP

19.5792

Average Volume (3m)

479,797

Shares Outstanding

72,201,565

Dividend Yield

PE Ratio

100.72

Earnings Per Share (EPS)

0.2

Revenue

270.26M

Net Profit

14.08M

Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurre... Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.kiniksa.com

Headquarters

London, Gbr

Founded

Kiniksa Pharmaceuticals International PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KNSA. The last closing price for Kiniksa Pharmaceuticals was US$19.72. Over the last year, Kiniksa Pharmaceuticals shares have traded in a share price range of US$ 16.56 to US$ 28.15.

Kiniksa Pharmaceuticals currently has 72,201,565 shares outstanding. The market capitalization of Kiniksa Pharmaceuticals is US$1.42 billion. Kiniksa Pharmaceuticals has a price to earnings ratio (PE ratio) of 100.72.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.41	2.1265560166	19.28	20.32	19.175	401678	19.69125942	CS
4	-0.07	-0.354251012146	19.76	20.9	18.12	610216	19.84624864	CS
12	-2.65	-11.8621307073	22.34	22.38	17.82	479797	19.86941026	CS
26	-6.9	-25.9496051147	26.59	28.15	17.82	405789	22.21150797	CS
52	-0.15	-0.756048387097	19.84	28.15	16.56	411859	21.58857477	CS
156	8.83	81.3075506446	10.86	28.15	7.36	395019	16.79399066	CS
260	1.39	7.5956284153	18.3	33	7.36	395764	16.70558987	CS

KNSA - Frequently Asked Questions (FAQ)

What is the current Kiniksa Pharmaceuticals share price?

The current share price of Kiniksa Pharmaceuticals is US$ 19.69

How many Kiniksa Pharmaceuticals shares are in issue?

Kiniksa Pharmaceuticals has 72,201,565 shares in issue

What is the market cap of Kiniksa Pharmaceuticals?

The market capitalisation of Kiniksa Pharmaceuticals is USD 1.42B

What is the 1 year trading range for Kiniksa Pharmaceuticals share price?

Kiniksa Pharmaceuticals has traded in the range of US$ 16.56 to US$ 28.15 during the past year

What is the PE ratio of Kiniksa Pharmaceuticals?

The price to earnings ratio of Kiniksa Pharmaceuticals is 100.72

What is the cash to sales ratio of Kiniksa Pharmaceuticals?

The cash to sales ratio of Kiniksa Pharmaceuticals is 5.25

What is the reporting currency for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals reports financial results in USD

What is the latest annual turnover for Kiniksa Pharmaceuticals?

The latest annual turnover of Kiniksa Pharmaceuticals is USD 270.26M

What is the latest annual profit for Kiniksa Pharmaceuticals?

The latest annual profit of Kiniksa Pharmaceuticals is USD 14.08M

What is the registered address of Kiniksa Pharmaceuticals?

The registered address for Kiniksa Pharmaceuticals is THIRD FLOOR, 23 OLD BOND STREET, LONDON, W1S 4PZ

What is the Kiniksa Pharmaceuticals website address?

The website address for Kiniksa Pharmaceuticals is www.kiniksa.com

Which industry sector does Kiniksa Pharmaceuticals operate in?

Kiniksa Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MNDRMobile health Network Solutions	US$ 0.934099 (183.66%)	451.07M
XOSXos Inc	US$ 6.245 (99.52%)	93.25M
STSSSharps Technology Inc	US$ 0.5185 (44.55%)	76.11M
YSXTYSX Tech Company Ltd	US$ 3.4999 (42.85%)	447.78k
AGHAureus Greenway Holdings Inc	US$ 5.47 (41.71%)	2.49M
WOKWORK Medical Technology Group Ltd	US$ 1.30 (-47.79%)	112.25M
EDITEditas Medicine Inc	US$ 2.0556 (-35.76%)	14.93M
MTLSMaterialise NV	US$ 5.98 (-35.14%)	2.63M
MULNMullen Automotive Inc	US$ 5.125 (-28.32%)	1.3M
JTAIJet AI Inc	US$ 7.32 (-27.88%)	7.39M
MNDRMobile health Network Solutions	US$ 0.934099 (183.66%)	452.2M
PLTRPalantir Technologies Inc	US$ 106.27 (-5.17%)	243.09M
ADTXAditxt Inc	US$ 0.1156 (-10.11%)	207.82M
APTOAptose Biosciences Inc	US$ 0.188 (25.42%)	181.99M
SMCISuper Micro Computer Inc	US$ 59.27 (-1.63%)	181.57M